MedTrace Logo

A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer

NCT00149279 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2016-09-22

No results posted yet for this study

Summary

To evaluate the survival benefit of para-aortic lymphadenectomy in potentially curative gastrectomy

Conditions

  • Gastric Neoplasm

Interventions

PROCEDURE

Surgery: D2 dissection

PROCEDURE

Surgery: D2+paraaortic dissection

Sponsors & Collaborators

  • Ministry of Health, Labour and Welfare, Japan

    collaborator OTHER_GOV

  • Japan Clinical Oncology Group

    lead OTHER

Principal Investigators

  • Mitsuru Sasako, MD · Gastric Surgery Division, National Cancer Center Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-07-31
Completion
2006-04-30

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149279 on ClinicalTrials.gov